Pliant Therapeutics, Inc.
US ˙ NasdaqGS ˙ US7291391057

SecurityPLRX / Pliant Therapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership3,042,133 shares
Ownership 5.00%
Citadel Advisors Llc ownership in PLRX / Pliant Therapeutics, Inc.

2026-02-09 - Citadel Advisors Llc has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,042,133 shares of Pliant Therapeutics, Inc. (US:PLRX). This represents 5.0 percent ownership of the company. In their previous filing dated 2026-01-30 , Citadel Advisors Llc had reported owning 3,037,695 shares, indicating an increase of 0.15 percent.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (PLRX) in the form of stock options. The firm currently holds call options representing 36,800 of underlying shares valued at $46,368 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2026-02-09 2026-02-09 13G 3,037,695 3,042,133 0.15 5.00 2.04
2026-01-30 2026-01-30 13G 2,991,915 3,037,695 1.53 4.90 0.00
2026-01-22 2026-01-22 13G 2,991,915 4.90

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PLRX / Pliant Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PLIANT THERAPEUTICS COM 729139105 3,226,599 643,267 24.90 4,066 29.01 0.0006
2026-02-17 2025-12-31 13F PLIANT THERAPEUTICS COM 729139105 2,583,332 243,864 10.42 3,152 -8.98 0.0005
2025-11-14 2025-09-30 13F PLIANT THERAPEUTICS COM 729139105 2,339,468 -16,431 -0.70 3,462 26.72 0.0005
2025-08-14 2025-06-30 13F PLIANT THERAPEUTICS COM 729139105 2,355,899 2,355,834 3,624,360.00 2,733 0.0005
2025-05-15 2025-03-31 13F PLIANT THERAPEUTICS COM 729139105 65 -401,624 -99.98 0 -100.00 0.0000
2025-02-14 2024-12-31 13F PLIANT THERAPEUTICS COM 729139105 401,689 366,635 1,045.91 5,290 1,249.49 0.0009
2024-11-14 2024-09-30 13F PLIANT THERAPEUTICS COM 729139105 35,054 -395,658 -91.86 393 -91.53 0.0001
2024-08-14 2024-06-30 13F PLIANT THERAPEUTICS COM 729139105 430,712 -1,271,034 -74.69 4,630 -81.74 0.0009
2024-05-15 2024-03-31 13F PLIANT THERAPEUTICS COM 729139105 1,701,746 123,232 7.81 25,356 -11.30 0.0049
2024-02-14 2023-12-31 13F PLIANT THERAPEUTICS COM 729139105 1,578,514 58,436 3.84 28,587 8.45 0.0057
2023-11-14 2023-09-30 13F PLIANT THERAPEUTICS COM 729139105 1,520,078 -92,829 -5.76 26,358 -9.81 0.0057
2023-08-14 2023-06-30 13F PLIANT THERAPEUTICS COM 729139105 1,612,907 498,079 44.68 29,226 -1.45 0.0060
2023-05-15 2023-03-31 13F PLIANT THERAPEUTICS COM 729139105 1,114,828 123,707 12.48 29,654 54.79 0.0065
2023-02-14 2022-12-31 13F PLIANT THERAPEUTICS COM 729139105 991,121 573,233 137.17 19,158 119.45 0.0045
2022-11-14 2022-09-30 13F PLIANT THERAPEUTICS COM 729139105 417,888 -965,439 -69.79 8,730 -21.22 0.0020
2022-08-15 2022-06-30 13F PLIANT THERAPEUTICS COM 729139105 1,383,327 5,819 0.42 11,081 14.75 0.0028
2022-05-16 2022-03-31 13F PLIANT THERAPEUTICS COM 729139105 1,377,508 40,382 3.02 9,657 -46.50 0.0020
2022-02-14 2021-12-31 13F PLIANT THERAPEUTICS COM 729139105 1,337,126 8,760 0.66 18,051 -19.50 0.0037
2021-11-15 2021-09-30 13F PLIANT THERAPEUTICS Cmn 729139105 1,328,366 129,961 10.84 22,423 -35.75 0.0047
2021-08-16 2021-06-30 13F PLIANT THERAPEUTICS COM 729139105 1,198,405 -23,775 -1.95 34,898 -27.40 0.0078
2021-05-21 2021-03-31 13F/A-1 PLIANT THERAPEUTICS COM 729139105 1,222,180 -10,078 -0.82 48,068 71.69 0.0118
2021-05-17 2021-03-31 13F PLIANT THERAPEUTICS COM 729139105 1,222,180 -10,078 48,068 0.0118
2021-02-16 2020-12-31 13F PLIANT THERAPEUTICS COM 729139105 1,232,258 2,825 0.23 27,997 0.54 0.0073
2020-11-16 2020-09-30 13F PLIANT THERAPEUTICS COM 729139105 1,229,433 -3,347 -0.27 27,847 -30.41 0.0079
2020-08-14 2020-06-30 13F PLIANT THERAPEUTICS Cmn 729139105 1,232,780 1,232,780 40,016 0.0143
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F PLIANT THERAPEUTICS COM Call 36,800 -11.96 46 -8.00 n/a n/a n/a
2026-02-17 2025-12-31 13F PLIANT THERAPEUTICS COM Call 41,800 188.28 51 138.10 n/a n/a n/a
2025-11-14 2025-09-30 13F PLIANT THERAPEUTICS COM Call 14,500 -62.24 21 -52.27 n/a n/a n/a
2025-08-14 2025-06-30 13F PLIANT THERAPEUTICS COM Call 38,400 1.05 45 -13.73 n/a n/a n/a
2025-05-15 2025-03-31 13F PLIANT THERAPEUTICS COM Call 38,000 124.85 51 -77.03 n/a n/a n/a
2025-02-14 2024-12-31 13F PLIANT THERAPEUTICS COM Call 16,900 -10.11 223 5.71 n/a n/a n/a
2024-11-14 2024-09-30 13F PLIANT THERAPEUTICS COM Call 18,800 -45.03 211 -42.78 n/a n/a n/a
2024-08-14 2024-06-30 13F PLIANT THERAPEUTICS COM Call 34,200 29.06 368 -6.85 n/a n/a n/a
2024-05-15 2024-03-31 13F PLIANT THERAPEUTICS COM Call 26,500 36.60 395 12.25 n/a n/a n/a
2024-02-14 2023-12-31 13F PLIANT THERAPEUTICS COM Call 19,400 -60.00 351 -58.21 n/a n/a n/a
2023-11-14 2023-09-30 13F PLIANT THERAPEUTICS COM Call 48,500 11.24 841 6.33 n/a n/a n/a
2023-08-14 2023-06-30 13F PLIANT THERAPEUTICS COM Call 43,600 -16.63 790 -43.21 n/a n/a n/a
2023-05-15 2023-03-31 13F PLIANT THERAPEUTICS COM Call 52,300 41.73 1,391 95.09 n/a n/a n/a
2023-02-14 2022-12-31 13F PLIANT THERAPEUTICS COM Call 36,900 -45.89 713 -49.96 n/a n/a n/a
2022-11-14 2022-09-30 13F PLIANT THERAPEUTICS COM Call 68,200 235.96 1,425 774.23 n/a n/a n/a
2022-08-15 2022-06-30 13F PLIANT THERAPEUTICS COM Call 20,300 163 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F PLIANT THERAPEUTICS COM Put 0 -100.00 0 n/a n/a n/a
2026-02-17 2025-12-31 13F PLIANT THERAPEUTICS COM Put 83,600 442.86 102 359.09 n/a n/a n/a
2025-11-14 2025-09-30 13F PLIANT THERAPEUTICS COM Put 15,400 -58.38 23 -47.62 n/a n/a n/a
2025-08-14 2025-06-30 13F PLIANT THERAPEUTICS COM Put 37,000 421.13 43 366.67 n/a n/a n/a
2025-05-15 2025-03-31 13F PLIANT THERAPEUTICS COM Put 7,100 -90.65 10 -99.10 n/a n/a n/a
2025-02-14 2024-12-31 13F PLIANT THERAPEUTICS COM Put 75,900 28.43 1,000 50.91 n/a n/a n/a
2024-11-14 2024-09-30 13F PLIANT THERAPEUTICS COM Put 59,100 0.51 663 4.75 n/a n/a n/a
2024-08-14 2024-06-30 13F PLIANT THERAPEUTICS COM Put 58,800 -0.17 632 -27.94 n/a n/a n/a
2024-05-15 2024-03-31 13F PLIANT THERAPEUTICS COM Put 58,900 51.03 878 24.22 n/a n/a n/a
2024-02-14 2023-12-31 13F PLIANT THERAPEUTICS COM Put 39,000 34.95 706 40.92 n/a n/a n/a
2023-11-14 2023-09-30 13F PLIANT THERAPEUTICS COM Put 28,900 -15.99 501 -19.58 n/a n/a n/a
2023-08-14 2023-06-30 13F PLIANT THERAPEUTICS COM Put 34,400 -27.73 623 -50.79 n/a n/a n/a
2023-05-15 2023-03-31 13F PLIANT THERAPEUTICS COM Put 47,600 40.41 1,266 93.28 n/a n/a n/a
2023-02-14 2022-12-31 13F PLIANT THERAPEUTICS COM Put 33,900 16.10 655 7.38 n/a n/a n/a
2022-11-14 2022-09-30 13F PLIANT THERAPEUTICS COM Put 29,200 610 n/a n/a n/a
2022-02-14 2021-12-31 13F PLIANT THERAPEUTICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F PLIANT THERAPEUTICS Cmn Put 14,800 250 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.